{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T22:47:47Z","timestamp":1785192467342,"version":"3.55.0"},"reference-count":27,"publisher":"BMJ","issue":"6","license":[{"start":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T00:00:00Z","timestamp":1654473600000},"content-version":"unspecified","delay-in-days":5,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U01 AI150508"],"award-info":[{"award-number":["U01 AI150508"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2022,5,20]]},"published-print":{"date-parts":[[2022,6]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Sub-Saharan Africa shoulders the highest burden of global sepsis and associated mortality. In high HIV and tuberculosis (TB) prevalent settings such as sub-Saharan Africa, TB is the leading cause of sepsis. However, anti-TB therapy is often delayed and may not achieve adequate blood concentrations in patients with sepsis. Accordingly, this multisite randomised clinical trial aims to determine whether immediate and\/or increased dose anti-TB therapy improves 28-day mortality for participants with HIV and sepsis in Tanzania or Uganda.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>This is a phase 3, multisite, open-label, randomised controlled clinical 2\u00d72 factorial superiority trial of (1) immediate initiation of anti-TB therapy and (2) sepsis-specific dose anti-TB therapy in addition to standard of care antibacterials for adults with HIV and sepsis admitted to hospital in Tanzania or Uganda. The primary endpoint is 28-day mortality. A sample size of 436 participants will provide 80% power for testing each of the main effects of timing and dose on 28-day mortality with a two-sided significance level of 5%. The expected main effect for absolute risk reduction is 13% and the expected OR for risk reduction is 1.58.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>This clinical trial will determine the optimal content, dosing and timing of antimicrobial therapy for sepsis in high HIV and TB prevalent settings. The study is funded by the National Institutes of Health in the US. Institutional review board approval was conferred by the University of Virginia, the Tanzania National Institute for Medical Research, and the Uganda National Council for Science and Technology. Study results will be published in peer-reviewed journals and in the popular press of Tanzania and Uganda. We will also present our findings to the Community Advisory Boards that we convened during study preparation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      ClinicalTrials.gov (\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT04618198\">NCT04618198<\/jats:ext-link>\n                      ).\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2022-061953","type":"journal-article","created":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T11:32:09Z","timestamp":1654515129000},"page":"e061953","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":7,"title":["Early empiric anti-\n                    <i>Mycobacterium tuberculosis<\/i>\n                    therapy for sepsis in sub-Saharan Africa: a protocol of a randomised clinical trial"],"prefix":"10.1136","volume":"12","clinical-trial-number":[{"clinical-trial-number":"nct04618198","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct04618198","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3687-6827","authenticated-orcid":false,"given":"Bibie","family":"Said","sequence":"first","affiliation":[{"name":"Department of Medicine, Kibong\u2019oto Infectious Diseases Hospital, Sanya Juu, United Republic of Tanzania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin","family":"Nuwagira","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Mbarara University of Science and Technology, Mbarara, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alphonce","family":"Liyoyo","sequence":"additional","affiliation":[{"name":"Department of Medicine, Kibong\u2019oto Infectious Diseases Hospital, Sanya Juu, United Republic of Tanzania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rinah","family":"Arinaitwe","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Mbarara University of Science and Technology, Mbarara, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Gitige","sequence":"additional","affiliation":[{"name":"Department of Medicine, Kibong\u2019oto Infectious Diseases Hospital, Sanya Juu, United Republic of Tanzania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhina","family":"Mushagara","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Mbarara University of Science and Technology, Mbarara, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Buzaare","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Mbarara University of Science and Technology, Mbarara, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Chongolo","sequence":"additional","affiliation":[{"name":"Department of Medicine, Kibong\u2019oto Infectious Diseases Hospital, Sanya Juu, United Republic of Tanzania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Jjunju","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Mbarara University of Science and Technology, Mbarara, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Precious","family":"Twesigye","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Mbarara University of Science and Technology, Mbarara, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R","family":"Boulware","sequence":"additional","affiliation":[{"name":"University of Minnesota Medical School Twin Cities, Minneapolis, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Conaway","sequence":"additional","affiliation":[{"name":"Department of Public Health Sciences, University of Virginia School of Medicine, Charlottesville, Virginia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Null","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and International Health, University of Virginia, Charlottesville, Virginia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania A","family":"Thomas","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and International Health, University of Virginia, Charlottesville, Virginia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott K","family":"Heysell","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and International Health, University of Virginia, Charlottesville, Virginia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4649-0511","authenticated-orcid":false,"given":"Christopher C","family":"Moore","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and International Health, University of Virginia, Charlottesville, Virginia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7866-5198","authenticated-orcid":false,"given":"Conrad","family":"Muzoora","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Mbarara University of Science and Technology, Mbarara, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0660-6930","authenticated-orcid":false,"given":"Stellah G","family":"Mpagama","sequence":"additional","affiliation":[{"name":"Department of Medicine, Kibong\u2019oto Infectious Diseases Hospital, Sanya Juu, United Republic of Tanzania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,6,6]]},"reference":[{"key":"2025121410523172000_12.6.e061953.1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.0287"},{"key":"2025121410523172000_12.6.e061953.2","unstructured":"WHO . Sepsis. Available: http:\/\/www.who.int\/sepsis\/en\/ [Accessed 27 Apr 2020]."},{"key":"2025121410523172000_12.6.e061953.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60446-1"},{"key":"2025121410523172000_12.6.e061953.4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32989-7"},{"key":"2025121410523172000_12.6.e061953.5","unstructured":"Moore CC , Jacob ST , Banura P . Etiology of sepsis in Uganda using a quantitative PCR-based TaqMan array card. Clin Infect Dis."},{"key":"2025121410523172000_12.6.e061953.6","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/S1473-3099(19)30695-4","article-title":"Mycobacterium tuberculosis bloodstream infection prevalence, diagnosis, and mortality risk in seriously ill adults with HIV: a systematic review and meta-analysis of individual patient data","volume":"20","author":"Barr","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"2025121410523172000_12.6.e061953.7","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofz140","article-title":"Effect of empiric anti-Mycobacterium tuberculosis therapy on survival among human immunodeficiency virus-infected adults admitted with sepsis to a regional referral hospital in Uganda","volume":"6","author":"Hazard","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"2025121410523172000_12.6.e061953.8","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.14207"},{"key":"2025121410523172000_12.6.e061953.9","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics10060739","article-title":"Population pharmacokinetics and significant under-dosing of anti-tuberculosis medications in people with HIV and critical illness","volume":"10","author":"Rao","year":"2021","journal-title":"Antibiotics"},{"key":"2025121410523172000_12.6.e061953.10","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1001\/jama.2018.6229","article-title":"Association of the quick sequential (sepsis-related) organ failure assessment (qSOFA) score with excess hospital mortality in adults with suspected infection in low- and middle-income countries","volume":"319","author":"Rudd","year":"2018","journal-title":"JAMA"},{"key":"2025121410523172000_12.6.e061953.11","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e31824e65d7"},{"key":"2025121410523172000_12.6.e061953.12","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/QAI.0000000000000970","article-title":"Empiric TB treatment of severely ill patients with HIV and presumed pulmonary TB improves survival","volume":"72","author":"Katagira","year":"2016","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2025121410523172000_12.6.e061953.13","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000000541"},{"key":"2025121410523172000_12.6.e061953.14","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(17)30243-8"},{"key":"2025121410523172000_12.6.e061953.15","unstructured":"WHO . Improving the diagnosis and treatment of smear-negative pulmonary and extra-pulmonary tuberculosis among adults and adolescents. Available: https:\/\/www.who.int\/hiv\/pub\/tb\/pulmonary\/en\/ [Accessed 7 Feb 2020]."},{"key":"2025121410523172000_12.6.e061953.16","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.14-0496"},{"key":"2025121410523172000_12.6.e061953.17","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.0071"},{"key":"2025121410523172000_12.6.e061953.18","doi-asserted-by":"crossref","DOI":"10.1186\/1475-2875-12-146","article-title":"Malaria is an uncommon cause of adult sepsis in south-western Uganda","volume":"12","author":"Auma","year":"2013","journal-title":"Malar J"},{"key":"2025121410523172000_12.6.e061953.19","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-11-144"},{"key":"2025121410523172000_12.6.e061953.20","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1164\/rccm.201806-1197OC","article-title":"Identifying novel sepsis subphenotypes using temperature trajectories","volume":"200","author":"Bhavani","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"2025121410523172000_12.6.e061953.21","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ejim.2015.12.011","article-title":"The alertness, gait and mortality of severely ill patients at two months after admission to a resource poor sub-Saharan hospital\u2014Why is post-discharge surveillance not routine everywhere?","volume":"28","author":"Nabayigga","year":"2016","journal-title":"Eur J Intern Med"},{"key":"2025121410523172000_12.6.e061953.22","doi-asserted-by":"publisher","DOI":"10.2307\/2530245"},{"key":"2025121410523172000_12.6.e061953.23","doi-asserted-by":"publisher","DOI":"10.1002\/sim.2864"},{"key":"2025121410523172000_12.6.e061953.24","doi-asserted-by":"publisher","DOI":"10.1186\/1756-0500-4-475"},{"key":"2025121410523172000_12.6.e061953.25","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/S0140-6736(16)00546-8","article-title":"Empirical tuberculosis therapy versus isoniazid in adult outpatients with advanced HIV initiating antiretroviral therapy (REMEMBER): a multicountry open-label randomised controlled trial","volume":"387","author":"Hosseinipour","year":"2016","journal-title":"Lancet"},{"key":"2025121410523172000_12.6.e061953.26","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1056\/NEJMoa1910708","article-title":"Systematic or test-guided treatment for tuberculosis in HIV-infected adults","volume":"382","author":"Blanc","year":"2020","journal-title":"N Engl J Med"},{"key":"2025121410523172000_12.6.e061953.27","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciq103"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2022-061953","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T18:52:41Z","timestamp":1765738361000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2022-061953"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":27,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,6,6]]},"published-print":{"date-parts":[[2022,6]]}},"alternative-id":["10.1136\/bmjopen-2022-061953"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2022-061953","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6]]}}}